drugset / Trial / NCT01830530

HIGH Altitude CArdiovascular REsearch in the ANDES

NCT01830530

Phase 4 Completed 100 enrolled Istituto Auxologico Italiano Bayer · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is aimed to assess the efficacy of combined treatment with two antihypertensive agents (telmisartan and nifedipine) in subjects with mild hypertension exposed to high altitude.

Timeline

Start
2012-05
Primary completion
2012-09
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nifedipine Other / unclassified 30 mg
Subject Telmisartan Other / unclassified 80 mg

Indications